DE69922684D1 - Verwendung von 2-methoxyestradiol als fungizide - Google Patents

Verwendung von 2-methoxyestradiol als fungizide

Info

Publication number
DE69922684D1
DE69922684D1 DE69922684T DE69922684T DE69922684D1 DE 69922684 D1 DE69922684 D1 DE 69922684D1 DE 69922684 T DE69922684 T DE 69922684T DE 69922684 T DE69922684 T DE 69922684T DE 69922684 D1 DE69922684 D1 DE 69922684D1
Authority
DE
Germany
Prior art keywords
compounds
fungi
methoxyestradiol
fungicides
estrogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69922684T
Other languages
English (en)
Other versions
DE69922684T2 (de
Inventor
J Green
E Papathanassiu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Casi Pharmaceuticals Inc
Original Assignee
Entremed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entremed Inc filed Critical Entremed Inc
Publication of DE69922684D1 publication Critical patent/DE69922684D1/de
Application granted granted Critical
Publication of DE69922684T2 publication Critical patent/DE69922684T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
DE69922684T 1998-08-11 1999-08-10 Verwendung von 2-methoxyestradiol als fungizide Expired - Fee Related DE69922684T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9614598P 1998-08-11 1998-08-11
US96145P 1998-08-11
PCT/US1999/018063 WO2000009101A2 (en) 1998-08-11 1999-08-10 Use of estrogenic compounds as anti-fungal agents

Publications (2)

Publication Number Publication Date
DE69922684D1 true DE69922684D1 (de) 2005-01-20
DE69922684T2 DE69922684T2 (de) 2005-10-06

Family

ID=22255771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69922684T Expired - Fee Related DE69922684T2 (de) 1998-08-11 1999-08-10 Verwendung von 2-methoxyestradiol als fungizide

Country Status (10)

Country Link
US (2) US6239123B1 (de)
EP (1) EP1124545B1 (de)
JP (1) JP2002522477A (de)
KR (1) KR20010074814A (de)
AT (1) ATE284682T1 (de)
AU (1) AU764266B2 (de)
CA (1) CA2339835C (de)
DE (1) DE69922684T2 (de)
ES (1) ES2234284T3 (de)
WO (1) WO2000009101A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US20040214807A1 (en) * 1993-08-06 2004-10-28 D'amato Robert J. Estrogenic compounds as anti-mitotic agents
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20020002294A1 (en) * 1997-09-24 2002-01-03 D' Amato Robert J. Estrogenic compounds as antiangiogenic agents
JP2002522477A (ja) 1998-08-11 2002-07-23 エントレメッド インコーポレイテッド 抗真菌薬としてのエストロゲン様化合物の使用
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US20050192258A1 (en) * 2000-08-18 2005-09-01 Agoston Gregory E. Antiangiogenic agents
US6995278B2 (en) * 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
AU2003208913A1 (en) * 2002-01-30 2003-09-02 Entremed, Inc. Non-steroidal analogs of 2-methoxyestradiol
AU2004275693A1 (en) * 2003-05-28 2005-04-07 Entremed, Inc. Antiangiogenic agents
AU2005222934B2 (en) 2004-03-12 2010-06-17 Entremed, Inc. Antiangiogenic agents
US20070004689A1 (en) * 2004-03-12 2007-01-04 Agoston Gregory E Antiangiogenic agents
AU2005309455A1 (en) * 2004-11-29 2006-06-01 Entremed, Inc. A method of administering anti-angiogenic agents and a method of treating disease using same
US10174070B2 (en) * 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US8168621B2 (en) * 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US20070185069A1 (en) * 2005-11-14 2007-08-09 Plum Stacy M Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
US20070176403A1 (en) * 2006-02-01 2007-08-02 Dennis Calderone Air adjustable seat
WO2007109312A2 (en) * 2006-03-20 2007-09-27 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol
WO2008094665A1 (en) * 2007-01-31 2008-08-07 Entremed, Inc. Method of treating amyloidosis mediated diseases
CN113106027B (zh) * 2021-04-25 2022-02-25 青岛农业大学 一种牡蛎内生真菌及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584271A (en) 1948-06-19 1952-02-05 Searle & Co Steroid derivatives and method for producing the same
US2846453A (en) 1957-05-28 1958-08-05 Searle & Co Alpha-ring-acylated estrone derivatives, and corresponding alcohols, their esters, and ethers
US3470218A (en) 1966-12-27 1969-09-30 Allied Chem New 2-substituted estrogenic steroids
US3410879A (en) 1967-04-12 1968-11-12 American Home Prod Process for preparing gonahexaenes
US3492321A (en) 1968-01-22 1970-01-27 Syntex Corp Cyclopropenyl estra, -1,3,5(10)-trienes
US3496272A (en) 1968-01-23 1970-02-17 American Home Prod Ester of 3-(2-propynyloxy)-estradiol
US3487155A (en) 1968-02-19 1969-12-30 Sandoz Ag Substituted estradiol alkyl ethers
GB1502635A (en) 1974-02-27 1978-03-01 Schering Ag Process for splitting steroid ethers
NL7613248A (nl) 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
US4172132A (en) 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US4994443A (en) 1982-12-20 1991-02-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US5001116A (en) 1982-12-20 1991-03-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US4522758A (en) 1983-12-22 1985-06-11 Eli Lilly And Company Method of preparing 2-fluoro-17β-estradiol
US4743597A (en) 1986-01-27 1988-05-10 Javitt Norman B Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
DE3625315A1 (de) 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
WO1990015816A1 (en) 1989-06-16 1990-12-27 The Upjohn Company Suramin type compounds and angiostatic steroids to inhibit angiogenesis
WO1993003729A1 (en) 1991-08-12 1993-03-04 Research Corporation Technologies, Inc. N-substituted phenoxazines for treating multidrug resistant cancer cells
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
DE4235657A1 (de) 1992-10-22 1994-06-23 Schering Ag Verfahren zum Alkylieren von Östronderivaten
US5643900A (en) 1993-07-02 1997-07-01 Fotsis; Theodore Method for treatment of pathological conditions associated with angiogenesis and preparation therefor
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5521168A (en) 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure
DE69731473T2 (de) * 1996-05-09 2005-10-27 Amrad Operations Pty. Ltd., Richmond Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen
US6136992A (en) 1997-03-13 2000-10-24 The United States Of America As Represented By The Department Of Health And Human Services 2-alkoxy estradiols and derivatives thereof
US6051726A (en) 1997-03-13 2000-04-18 Pharm-Eco Laboratories, Inc. Synthesis of 2-alkoxyestradiols
US6011023A (en) 1997-08-27 2000-01-04 Alcon Laboratories, Inc. Angiostatic steroids
DE69942645D1 (en) 1998-01-09 2010-09-16 Body Corporate Of The State Of Synthese von combretastatin a-4 prodrugs
JP2002522477A (ja) 1998-08-11 2002-07-23 エントレメッド インコーポレイテッド 抗真菌薬としてのエストロゲン様化合物の使用
WO2000025780A1 (en) * 1998-10-29 2000-05-11 Bristol-Myers Squibb Company Compounds derived from an amine nucleus that are inhibitors of impdh enzyme

Also Published As

Publication number Publication date
CA2339835C (en) 2008-12-16
US6239123B1 (en) 2001-05-29
JP2002522477A (ja) 2002-07-23
US6605622B2 (en) 2003-08-12
US20010044432A1 (en) 2001-11-22
ATE284682T1 (de) 2005-01-15
CA2339835A1 (en) 2000-02-24
ES2234284T3 (es) 2005-06-16
KR20010074814A (ko) 2001-08-09
WO2000009101A3 (en) 2001-06-21
EP1124545A2 (de) 2001-08-22
WO2000009101A2 (en) 2000-02-24
DE69922684T2 (de) 2005-10-06
AU764266B2 (en) 2003-08-14
EP1124545B1 (de) 2004-12-15
AU5395999A (en) 2000-03-06

Similar Documents

Publication Publication Date Title
DE69922684D1 (de) Verwendung von 2-methoxyestradiol als fungizide
BR0107943A (pt) Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos
ES2153076T3 (es) Agentes herbicidas basados en bencisoxazol y bencisotiazol sustituidos.
ATE212546T1 (de) Behandlung von neurodegenerativen zuständen mittels nimesulide
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
DE69735949D1 (de) Zusammensetzung geeignet zur behandlung der pferdelahmheit
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
CY1105395T1 (el) Αναστολη της raf κινασης χρησιμοποιωντας αρυλικες και ετepοαρυλικες υποκατεστημενες ετepοκυκλικες ουριες
ATE122205T1 (de) Fungizide zusammensetzung zur behandlung von saatgut.
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE232191T1 (de) Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
DE69727948D1 (de) Sordarinderivate
EE04711B1 (et) Antiseptiline kompositsioon, puidust või muust materjalist põhimiku töötlemismeetod, puidu või muu materjali kaitsmismeetod, oksatiasiini ühendi, pluss ühe või mitme kvaternaarse ammooniumiühendi ja triasooliühendi kasutamine
DE69716056T2 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ID26929A (id) Fungisida
DE69813833T2 (de) 4-cyano-4-deformylsordarizin-derivate
ATE241979T1 (de) 4-cyano-4-deformylsordarinderivate
IL148336A0 (en) Medicaments that contain xenogenic oligo-or/and polyribonucleotides
DE69927815D1 (de) Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden
ATE172357T1 (de) Von pilzlichen stämmen von pyrenophora teres abgeleitete fungizide und insektizide verbindungen und zusammensetzungen
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
HUP9800262A2 (hu) Fungicidek
ATE292970T1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee